DIOPTRA Early Dynamic Screening for Colorectal Cancer via Novel Protein Biomarkers Reflecting Biological Initiation Mechanisms
- Coordinator
- Erevnitiko Panepistimiako Institouto Systimaton Epikoinonion Kai Ypologiston, Greece
- Runs
- 1 January 2023 to 31 December 2026
- Status
- Running
- EU funding
- €13.6m
- Total cost
- €13.6m
- Partners
- 30 organisations in 16 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101096649
What the project is doing
In the project's own words, from its summary on CORDIS.
DIOPTRA aims to introduce a front-line screening tool that will consider risk factors and protein biomarkers for pinpointing individuals at a high risk for colorectal cancer (CRC) incidence. Tissue & blood samples will be examined towards a discriminative set of prognostic proteins that are detectable via standard bloodwork and can indicate a need for further evaluation (i.e. colonoscopy). Other data (e.g. medical, behavioural) will also be considered as potential risk factors.
Artificial intelligence (AI) will be leveraged for assessing prognostic power, while personalised behavioural change will be promoted based on modifiable risk factors. Given the low citizen participation on CRC screening across EU, DIOPTRA seeks to broaden the evaluated population, boosting participation rates and bypassing age screening thresholds. This action is part of the Cancer Mission cluster of projects on ‘Prevention, including Screening’.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Erevnitiko Panepistimiako Institouto Systimaton Epikoinonion Kai Ypologiston | Athina | Greece | Coordinator |
| Medizinische Universitat Graz | Graz | Austria | Participant |
| Ainigma Technologies | Leuven | Belgium | Participant |
| Centre Hospitalier Universitaire De Liege | Liege | Belgium | Participant |
| European Hospital and Healthcare Federation | Bruxelles / Brussel | Belgium | Participant |
| Bloks Zdravni I Sotsialni Grizhi Eood | Sofia | Bulgaria | Participant |
| Martel GmbH | Dubendorf | Switzerland | Associatedpartner |
| Sphynx Technology Solutions AG | Zug | Switzerland | Associatedpartner |
| Cscy Computer Solutions Cyprus Ltd | Nicosia | Cyprus | Participant |
| Csi Center for Social Innovation Ltd | Nicosia | Cyprus | Participant |
| Linac-Pet Scan Opco Limited | Limassol | Cyprus | Participant |
| Vilabs (cy) Ltd | Limassol | Cyprus | Participant |
| Komiteen for Sundhedsoplysning | Kobenhavn | Denmark | Participant |
| Region Midtjylland | Viborg | Denmark | Participant |
| Region Syddanmark | Vejle | Denmark | Participant |
| D.tsakalidis-G.domalis Oe | Patra | Greece | Participant |
| Ethniko Kai Kapodistriako Panepistimio Athinon | Athina | Greece | Participant |
| Geniko Antikarkiniko Ogkologiko Nosokomeio Athinon O Agios Savvas | Athina | Greece | Participant |
| Panepistimio Ioanninon | Ioannina | Greece | Participant |
| Protavio Monoprosopi E.p.e | Glyfada | Greece | Participant |
| Fundacion Burgos Por La Investigacion De La Salud | Burgos | Spain | Participant |
| Klinicka Bolnica Dubrava | Zagreb | Croatia | Participant |
| I2grow Innovation to Grow SRL | Milano | Italy | Participant |
| Uab Teraglobus | Vilnius | Lithuania | Participant |
| Netcompany S.a. | Luxembourg | Luxembourg | Participant |
| Smartsol Sia | Riga | Latvia | Participant |
| Arthur's Legal BV | Amsterdam | Netherlands | Participant |
| Tecreando B.v. | Amsterdam | Netherlands | Participant |
| Univerzitetni klinicni center Maribor | Maribor | Slovenia | Participant |
| Cambridge Medical Academy Ltd | Cambridge | United Kingdom | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI